← All comparisons
Head-to-head · FAERS comparison

Amoxicillin vs Doxycycline Hyclate: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

AmoxicillinDoxycycline Hyclate
Drug class––
Brand names––
FAERS reports75,88267,065
Serious80%73%
Death outcome5,0236,708
Boxed warningNoNo

Signals both drugs share

ReactionAmoxicillinDoxycycline HyclateLabel screen (A / B)
Nephrogenic anaemia661 · PRR 45.4403 · PRR 29.4Not in label — unassessed / Not in label — unassessed
Rebound acid hypersecretion440 · PRR 46.2263 · PRR 29.2Not in label — unassessed / Not in label — unassessed
Hyperparathyroidism secondary343 · PRR 43.2224 · PRR 30.3Not in label — unassessed / Not in label — unassessed
Chronic kidney disease-mineral and bone disorder185 · PRR 57.3119 · PRR 38.8Not in label — unassessed / Not in label — unassessed
Amyloid arthropathy59 · PRR 3,204.455 · PRR 1,878.3Not in label — unassessed / Not in label — unassessed

Labeled signals distinctive to Amoxicillin

Labeled signals distinctive to Doxycycline Hyclate

Common questions

Which has more reported side effects, Amoxicillin or Doxycycline Hyclate?

Amoxicillin has 75,882 FAERS reports and Doxycycline Hyclate 67,065. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (80% vs 73%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Amoxicillin and Doxycycline Hyclate share?

Both drugs carry disproportionality signals for nephrogenic anaemia, rebound acid hypersecretion, hyperparathyroidism secondary, chronic kidney disease-mineral and bone disorder, amyloid arthropathy. Shared signals often reflect a shared drug class or the condition both are used for.

Is Amoxicillin or Doxycycline Hyclate safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.